N. la Cour Freiesleben, T. A. Gerds, J. L. Forman, J. D. Silver, A

Slides:



Advertisements
Similar presentations
Chromosomal polymorphisms are associated with female infertility and adverse reproductive outcomes after infertility treatment: a 7-year retrospective.
Advertisements

Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis  Sesh Kamal Sunkara, Jyotsna Pundir,
Modified natural cycle IVF and mild IVF: a 10 year Swedish experience
Chromosomal polymorphisms are associated with female infertility and adverse reproductive outcomes after infertility treatment: a 7-year retrospective.
Attitudes and policies regarding access to fertility care and assisted reproductive technologies in Israel  Daniel Sperling, Yael Simon  Reproductive.
Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C
Diet and endometriosis risk: A literature review
M. Leyder, M. De Vos, B. Popovic-Todorovic, M. Dujardin, P. Devroey, H
Multiple-dose and double-dose versus single-dose administration of methotrexate for the treatment of ectopic pregnancy: a systematic review and meta-analysis 
Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis  Mireia González-Comadran, Montserrat Durán,
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response  William L. Ledger, Bart C.J.M. Fauser, Paul.
Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction  J.-C. Arce, A. Balen, P. Platteau, G. Pettersson,
Bruce S. Shapiro, Said T. Daneshmand, Humberto Restrepo, Forest C
A. Osman, J. Pundir, M. Elsherbini, S. Dave, T. El-Toukhy, Y. Khalaf 
Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate  Claus Yding Andersen,
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction  Antonio La Marca, Giovanni D’Ippolito 
Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol  Qi Yao, Yuanjiao Liang, Yong.
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH  George Griesinger, Daniel B. Shapiro, Efstratios.
Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors  Nikolaos P. Polyzos, Dominic Stoop, Christophe.
In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation 
Ovarian response to 150 µg corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study  Tamara Lerman, Marion Depenbusch,
Amir Wiser, Einat Shalom-Paz, Jordana H
Fresh transfer outcome predicts the success of a subsequent frozen transfer utilizing blastocysts of the same cohort  L.F. Doherty, J.R. Martin, U. Kayisli,
HDlive ultrasound images in assisted reproduction treatment
Establishment and validation of a score to predict ovarian response to stimulation in IVF  Clelia Chalumeau, Jessika Moreau, Nicolas Gatimel, Clementine.
Why are reproductive cancers more common in nulliparous women?
Perinatal outcomes after stimulated versus natural cycle IVF: a systematic review and meta-analysis  Mohan Shashikant Kamath, Richard Kirubakaran, Mariano.
K. Gersak, A. Veble  Reproductive BioMedicine Online 
Moniek van der Zanden, Annemiek W. Nap  Reproductive BioMedicine Online 
Hillary B. Alberta, Roberta M. Berry, Aaron D. Levine 
S Munné, E Fragouli, P Colls, MG Katz-Jaffe, WB Schoolcraft, D Wells 
Mikkel Rosendahl, M. D. , Claus Yding Andersen, D. M. Sc
Sarah McCredie, William Ledger, Christos A. Venetis 
Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study  A. Nasr  Reproductive BioMedicine Online 
Cumulative live-birth delivery after IVF/ICSI since the progressive introduction of single- embryo transfer  D. De Neubourg, C. Daels, M. Elseviers, K.
Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis  Georg Griesinger, Robert Boostanfar, Keith.
John L. Yovich, Kevin N. Keane, Gayatri Borude, Satvinder S
Jyotsna Pundir, Sesh Kamal Sunkara, Tarek El-Toukhy, Yacoub Khalaf 
Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype  C. Dechanet, C. Castelli,
Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction  Kathrine Birch Petersen, Nina Gros Pedersen, Anette.
Donor information considered important to donors, recipients and offspring: an Australian perspective  I.S. Rodino, P.J. Burton, K.A. Sanders  Reproductive.
A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor  X.J. Sun, L. Jiang, L.C. Ji, R. Nie,
Mark P. Connolly, Maarten J
Mid-follicular LH supplementation in women aged 35–39 years undergoing ICSI cycles: a randomized controlled study  R Matorras, B Prieto, A Exposito, R.
V Isachenko, E Isachenko, R Kreienberg, M Woriedh, JM Weiss 
Cumulative delivery rates after ICSI with donor spermatozoa in different age groups  Michaël De Brucker, Michel Camus, Patrick Haentjens, Jacques Francotte,
Endometrial thickness as a predictor of pregnancy outcomes in fresh IVF–ICSI cycles  Xi Yuan, Sotirios H. Saravelos, Qiong Wang, Yanwen Xu, Tin-Chiu.
Intra-cycle variation of the uterine cavity indentation assessed with three-dimensional ultrasound in natural and stimulated cycles  Sotirios H. Saravelos,
The value of HCG serum concentrations after trigger in predicting pregnancy and live birth rates in IVF–ICSI  Jianjun Zhou, Shanshan Wang, Bin Wang, Junxia.
Does ovarian stimulation regimen affect IVF outcome
Follicle recruitment determines IVF productivity rate via the number of embryos frozen and subsequent transfers  James D. Stanger, John L. Yovich  Reproductive.
Stephen C. Collins, Esther Chan  Reproductive BioMedicine Online 
GnRH antagonist pre-treatment: one centre's experience for IVF–ICSI cycle scheduling  Veronique Viardot-Foucault, Sadhana Nadarajah, Weng Kit Lye, Heng.
Variation in antral follicle counts at different times in the menstrual cycle: does it matter?  Dimitrios Mavrelos, Ali Al Chami, Vikram Talaulikar, Elizabeth.
The effect of protein supplement concentration in embryo transfer medium on clinical outcome of IVF/ICSI cycles: a prospective, randomized clinical trial 
Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature  Micah J. Hill, Gary Levy, Eric D. Levens 
The Alpha Consensus Meeting on the professional status of the clinical embryologist: proceedings of an expert meeting    Reproductive BioMedicine Online 
Is parental consanguinity associated with reduced ovarian reserve?
Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF  Thomas Freour, Lionel Dessolle, Miguel Jean, Damien Masson,
Ovarian reserve screening before contraception?
Cryobanking of human ovarian tissue: do women still want their tissue stored beyond 5 years?  Kirsten Tryde Macklon, Erik Ernst, Anders Nyboe Andersen,
Mariana M. Piccolomini, Mariana Nicolielo, Tatiana C. S
Live birth following early follicular phase oocyte collection and vitrified-warmed embryo transfer 8 days later  Safak Hatırnaz, Ebru Hatırnaz, Baris.
A. G. Sutcliffe, J. T. Manning, A. Katalanic, A. Ludwig, M. Mehta, J
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.
M. Franz, J. Ott, A. Watrelot, L. Küssel, H. Husslein 
Fertility in cancer patients after cryopreservation of one ovary
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive.
Presentation transcript:

Risk charts to identify low and excessive responders among first-cycle IVF/ICSI standard patients  N. la Cour Freiesleben, T.A. Gerds, J.L. Forman, J.D. Silver, A. Nyboe Andersen, B. Popovic-Todorovic  Reproductive BioMedicine Online  Volume 22, Issue 1, Pages 50-58 (January 2011) DOI: 10.1016/j.rbmo.2010.08.010 Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Risk charts for identification of standard IVF/ICSI patients’ risks of low and excessive ovarian responses in the first treatment cycle. Based on the total antral follicle count (AFC) (2–10mm) and the female age (years), a patient’s estimated risk (%) of low response (seven or less follicles) is identified from the top chart. Based on the total AFC and the spontaneous cycle length (days), a patient’s estimated risk (%) of excessive response (20 or more follicles) is identified from the bottom chart. The identified risks correspond to a starting dose of 150IU rFSH/day. Reproductive BioMedicine Online 2011 22, 50-58DOI: (10.1016/j.rbmo.2010.08.010) Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

Figure 2 Example of how risk estimates of low and excessive ovarian responses to a dose of 150IU rFSH/day (Figure 1) may be used for individual rFSH dosing in standard patients’ first IVF/ICSI treatment cycle. Along the diagonal where the predicted risk of low response is equal to the risk of excessive response, the dose is 150IU. The dose increases with increasing risk of low response and with decreasing risk of excessive response. Conversely, the dose decreases with increasing risk of excessive response and with decreasing risk of low response. The circles represent the predicted risks for each patient. Clinicians (and patients) may indeed have their own preferences regarding risks versus a reasonable dose in each individual case. Reproductive BioMedicine Online 2011 22, 50-58DOI: (10.1016/j.rbmo.2010.08.010) Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions